Search results

Forskare har tittat på om gång som träningsform kan minska risken för knäsmärta och om det kan leda till strukturella skillnader som ses med hjälp av röntgenbilder. I en amerikansk studie har forskare studerat huruvida gång som träningsform kan ha någon koppling till knäartrosens progress såväl när det kommer till symtom som strukturella skillnader som kan ses med hjälp av röntgen. Forskarna i stu

https://www.artrosportalen.lu.se/artikel/kan-knasmarta-minskas-med-hjalp-av-gang - 2025-12-17

I en ny studie har 60 000 svenska tvillingar studerats. Forskare har undersökt vilken roll genetiska faktorer spelar i utvecklingen av handartros. Den genetiska faktorn verkar vara starkt bidragande till att en vid besök hos specialistvården blir diagnosticerad med handartros. I studien jämförde forskarna förekomsten av handartros som diagnosticerats i specialistvården, många gånger hos en reumato

https://www.artrosportalen.lu.se/artikel/genetik-kan-forklara-varfor-manga-drabbas-av-handartros - 2025-12-17

Forskare har studerat vad som avhjälper smärta vid knä- och höftartros bäst, fysiska vårdbesök eller en digital tjänst. I en ny svensk studie har forskare tittat närmre på vad som avhjälper smärta vid knä- och höftartros bäst, fysiska vårdbesök eller digital vård. Den digitala vården erhölls i studien genom tjänsten Joint Academy. Majoriteten av studiedeltagarna hade knäartros (64%) och resterande

https://www.artrosportalen.lu.se/artikel/artrossmarta-kan-avhjalpas-saval-fysiska-som-digitala-vardtjanster - 2025-12-17

I en ny studie som publicerats i The British Journal of Sports Medicine, utmanas det vanliga antagandet om att en främre korsbandsskada inte kan läka av sig själv. Det främre korsbandet (på engelska ofta förkortat ACL) är det ligament som huvudsakligen stabiliserar knäet. Bristningar i det främre korsbandet ses oftast hos unga, aktiva personer och det kan ha förödande konsekvenser. Den vanligaste

https://www.artrosportalen.lu.se/artikel/ny-studie-visar-att-bristning-i-framre-korsbandet-kan-laka-utan-operation - 2025-12-17

Vi följer Amanda Sjögren under hennes tid som doktorand och tar reda på mer om vad hennes jobb innebär och vad målet med hennes forskning är. Forskning sker på många olika nivåer och en forskare börjar ofta sin resa som doktorand. Tidigare i år började Amanda Sjögren som doktorand hos oss vid enheten för klinisk epidemiologi, ortopedi, vid Lunds universitet. Vid några tillfällen under hennes tid h

https://www.artrosportalen.lu.se/artikel/reportage-folj-doktoranden-som-vill-bidra-till-artrosforskning-pa-molekylar-niva - 2025-12-17

Detta är andra delen av reportageserien där vi följer Amanda Sjögren, doktorand vid Lunds universitet. Vi följer Amanda Sjögren under hennes tid som doktorand vid Lunds universitet. Har du missat första delen hittar du den genom att klicka här. Amanda berättar att hon tycker det är intressant att arbeta med artros eftersom det är en sjukdom som drabbar så många och som det i dagsläget inte finns n

https://www.artrosportalen.lu.se/artikel/reportage-andra-delen-om-doktoranden-som-vill-bidra-till-artrosforskning-pa-molekylar-niva - 2025-12-17

In a new Swedish study by Lund University on comorbidities in osteoarthritis, researchers studied if people with osteoarthritis are at an increased risk for cancer compared to people without osteoarthritis. The study focused on the four most common cancer types, lung, colon, breast, and prostate cancer. Researchers found no differences in the risk of being diagnosed with colon cancer if you had os

https://www.arthritisportal.lu.se/article/oa-linked-cancer - 2025-12-17

Previous studies from Iceland have shown how osteoarthritis is often inherited and can be traced back several generations. A gene (genetic predisposition) is a segment of DNA containing hereditary information and is inherited from our biological parents. A new international study published in the high-ranking scientific journal Cell has discovered that a large number of genes are associated with o

https://www.arthritisportal.lu.se/article/your-genes-play-part-development-oa-and-perceived-joint-pain - 2025-12-17

Devil's Claw (Harpagophytum procumbens) is a plant in the sesame family native South Africa that has long been used as a herbal medicine to treat a number of different diseases. The plant is believed to be able to reduce joint pain and joint stiffness as it is said to have analgesic and anti-inflammatory properties. However, the actual properties of devil's claw are yet not fully understood. There

https://www.arthritisportal.lu.se/article/devils-claw-herbal-medicine-continued-uncertain-effect-oa-pain - 2025-12-17

Osteoarthritis has been described as the 15th most common cause of so-called “years lived with disability” (YLDs) in the world, which is a measure used to shed light on the burden of various diseases on society. According to the researchers, the economic costs caused by the disease correspond to about 1-2.5% of the gross domestic product (GDP) in most countries. A new article from a group of Ameri

https://www.arthritisportal.lu.se/article/global-burden-osteoarthritis - 2025-12-17

In a new Swedish study by Lund University, researchers looked at how common it is with comorbidities in osteoarthritis of the knee and/or hip. The study was published in the American journal Arthritis Care & Research. The study analyzed data collected from the province of Scania's population between the years 1998 and 2017. Newly diagnosed osteoarthritis patients were at a slightly higher risk of

https://www.arthritisportal.lu.se/article/common-comorbidities-osteoarthritis - 2025-12-17

Earlier in October, we reported on a research study that showed that platelet-rich plasma (PRP) injections for treating osteoarthritis of the knee did not have a better effect on OA symptoms than placebo. Last week, results from a new study on PRP were published. The researchers concluded that PRP injections had no effect on ankle OA compared to placebo. The Dutch study included 100 ankle OA patie

https://www.arthritisportal.lu.se/article/effect-prp-ankle-oa-no-better-placebo - 2025-12-17

The painkiller tanezumab was not approved by the European Medicine's Agency. At the beginning of 2021, news came that tanezumab, a new pain medication, would be launched in the US and Europe.  However, in March, tanezumab suffered a setback in the United States when the US Food and Drug Administration rejected the drug for osteoarthritis pain. There was continued uncertainty about the launch of th

https://www.arthritisportal.lu.se/article/not-approved-eu-another-setback-drug-tanezumab - 2025-12-17

Tramadol is an increasingly common drug prescribed for pain. Tramadol is a synthetic opioid (manufactured in a lab) that differs somewhat in its chemical structure compared to the natural opioid codeine. Other opioids include morphine and heroin. All opioids have analgesic properties and are extremely addictive. In a new study based on primary care data from Spain, the risks of a number of side ef

https://www.arthritisportal.lu.se/article/many-risks-painkiller-tramadol - 2025-12-17

In a new meta-analysis (a compilation of results from a number of different research studies), the benefits and side effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), paracetamol, and opioids have been studied. The research study included data from 181 publications describing 192 clinical trials involving a total of over 100,000 patients. The researchers found that the NSAID etoricoxib (6

https://www.arthritisportal.lu.se/article/benefits-and-side-effects-common-pain-meds-osteoarthritis-knee-and-hip - 2025-12-17

A Chinese research group has compiled data from 88 different scientific studies on the prevalence of knee osteoarthritis. The studies were from all around the world and together included more than 10 million people. The researchers estimated that for individuals aged 40 years and older, the global prevalence of knee osteoarthritis is around 23%. This means that almost every fourth person over the

https://www.arthritisportal.lu.se/article/how-common-knee-osteoarthritis - 2025-12-17

PRP treatment (platelet-rich plasma) is a relatively new experimental treatment that is often marketed to be effective for patients with osteoarthritis. However, there is a lack of high-quality research claiming the effectiveness of the treatment. Researchers from Brazil have recently published results from a small clinical trial (including 61 patients) evaluating three different treatments. The p

https://www.arthritisportal.lu.se/article/prp-injections-no-more-effective-placebo - 2025-12-17

Doctors Jack Cush, Martin Englund, Gillian Hawker, Tihuna Neogi, and Kent Kwoh discuss the best OA research from the 2021 ACR (American College of Rheumatology) conference, including a new study indicating that the diabetes medicine metformin lowers the risk of developing osteoarthritis. Dr. Jack Cush is a professor of internal medicine at The University of Texas Southwestern Medical School, in th

https://www.arthritisportal.lu.se/article/osteoarthritis-roundtable-best-acr-conference-2021 - 2025-12-17

In a recent study, a group of scientists have evaluated the burden of osteoarthritis over the past three decades, using data from the worldwide initiative ”Global Burden of Disease study 2019.  The results show that the number of people affected by osteoarthritis has increased by about 113 percent in 30 years, from about 248 million in year 1990 to about 530 million in year 2019. The authors concl

https://www.arthritisportal.lu.se/article/increased-burden-osteoarthritis-world - 2025-12-17

Researchers from Australia have investigated the incidence of obesity in patients with OA undergoing knee replacement. In a recent study from Australia researchers have investigated the incidence of obesity in patients undergoing knee replacements because of their OA. The results were compared to the incidence of obesity in the general population. The results show that of the 56 000 patients who u

https://www.arthritisportal.lu.se/article/there-link-between-oa-and-obesity - 2025-12-17